MYCN and neoplasm: These differences may be related to the number of cases in each study group or the biological origin of the analyzed samples [some researchers evaluated the MYCN gene status in tumor specimens and bone marrow aspirates, without distinguishing between primary and metastatic sample origin (6, 12, 18)].